Wastewater and seroprevalence for pandemic preparedness : variant analysis, vaccination effect, and hospitalization forecasting for SARS-CoV-2, in Jefferson County, Kentucky
Despite wide scale assessments, it remains unclear how large-scale SARS-CoV-2 vaccination affected the wastewater concentration of the virus or the overall disease burden as measured by hospitalization rates. We used weekly SARS-CoV-2 wastewater concentration with a stratified random sampling of seroprevalence, and linked vaccination and hospitalization data, from April 2021-August 2021 in Jefferson County, Kentucky (USA). Our susceptible (S), vaccinated (V), variant-specific infected I1 and I2, recovered (R), and seropositive (T) model SVI2RT tracked prevalence longitudinally. This was related to wastewater concentration. The 64% county vaccination rate translated into about 61% decrease in SARS-CoV-2 incidence. The estimated effect of SARS-CoV-2 Delta variant emergence was a 24-fold increase of infection counts, which corresponded to an over 9-fold increase in wastewater concentration. Hospitalization burden and wastewater concentration had the strongest correlation (r = 0.95) at 1 week lag. Our study underscores the importance of continued environmental surveillance post-vaccine and provides a proof-of-concept for environmental epidemiology monitoring of infectious disease for future pandemic preparedness.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - year:2023 |
---|---|
Enthalten in: |
medRxiv : the preprint server for health sciences - (2023) vom: 28. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Holm, Rochelle H [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 15.12.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1101/2023.01.06.23284260 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351675531 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM351675531 | ||
003 | DE-627 | ||
005 | 20231227131101.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2023.01.06.23284260 |2 doi | |
028 | 5 | 2 | |a pubmed24n1225.xml |
035 | |a (DE-627)NLM351675531 | ||
035 | |a (NLM)36656780 | ||
035 | |a (PII)2023.01.06.23284260 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Holm, Rochelle H |e verfasserin |4 aut | |
245 | 1 | 0 | |a Wastewater and seroprevalence for pandemic preparedness |b variant analysis, vaccination effect, and hospitalization forecasting for SARS-CoV-2, in Jefferson County, Kentucky |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 15.12.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a Despite wide scale assessments, it remains unclear how large-scale SARS-CoV-2 vaccination affected the wastewater concentration of the virus or the overall disease burden as measured by hospitalization rates. We used weekly SARS-CoV-2 wastewater concentration with a stratified random sampling of seroprevalence, and linked vaccination and hospitalization data, from April 2021-August 2021 in Jefferson County, Kentucky (USA). Our susceptible (S), vaccinated (V), variant-specific infected I1 and I2, recovered (R), and seropositive (T) model SVI2RT tracked prevalence longitudinally. This was related to wastewater concentration. The 64% county vaccination rate translated into about 61% decrease in SARS-CoV-2 incidence. The estimated effect of SARS-CoV-2 Delta variant emergence was a 24-fold increase of infection counts, which corresponded to an over 9-fold increase in wastewater concentration. Hospitalization burden and wastewater concentration had the strongest correlation (r = 0.95) at 1 week lag. Our study underscores the importance of continued environmental surveillance post-vaccine and provides a proof-of-concept for environmental epidemiology monitoring of infectious disease for future pandemic preparedness | ||
650 | 4 | |a Preprint | |
650 | 4 | |a seroprevalence | |
650 | 4 | |a vaccination | |
650 | 4 | |a wastewater | |
700 | 1 | |a Rempala, Grzegorz A |e verfasserin |4 aut | |
700 | 1 | |a Choi, Boseung |e verfasserin |4 aut | |
700 | 1 | |a Brick, J Michael |e verfasserin |4 aut | |
700 | 1 | |a Amraotkar, Alok R |e verfasserin |4 aut | |
700 | 1 | |a Keith, Rachel J |e verfasserin |4 aut | |
700 | 1 | |a Rouchka, Eric C |e verfasserin |4 aut | |
700 | 1 | |a Chariker, Julia H |e verfasserin |4 aut | |
700 | 1 | |a Palmer, Kenneth E |e verfasserin |4 aut | |
700 | 1 | |a Smith, Ted |e verfasserin |4 aut | |
700 | 1 | |a Bhatnagar, Aruni |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t medRxiv : the preprint server for health sciences |d 2020 |g (2023) vom: 28. Nov. |w (DE-627)NLM310900166 |7 nnns |
773 | 1 | 8 | |g year:2023 |g day:28 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2023.01.06.23284260 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |j 2023 |b 28 |c 11 |